34 Lives

34 Lives, a healthcare firm based in West Lafayette, Indiana, specializes in the rehabilitation of donated kidneys for transplantation, aiming to address the critical shortage of viable organs. The company focuses on extending the safe preservation times for the thousands of kidneys that are discarded each year, thereby improving the chances of successful transplants for the over 96,000 individuals on the waiting list in the U.S. Formerly known as Renovera, 34 Lives employs innovative processes that allow kidneys to be returned to near-normal body temperatures for functionality assessment, enhancing their viability for transplantation. The company has attracted interest from investors and has received funding through government programs such as the SBIR, which supports biotechnology initiatives. Its technology stands at the intersection of organ preservation and transplantation science, positioning it as a disruptor in the healthcare market. With a strong value proposition centered on saving lives and improving transplant outcomes, 34 Lives is poised for future growth, potentially expanding its focus to include partnerships with transplant centers and further advancements in organ preservation technologies to increase the availability of life-saving kidneys.